SEARCH:   Advanced

Blood, 15 August 2004, Vol. 104, No. 4, pp. 1075-1082. Prepublished online as a Blood First Edition Paper on March 23, 2004; DOI 10.1182/blood-2003-06-1937. This Article Full Text (PDF) All Versions of this Article: 2003-06-1937v1 104/4/1075    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Manley, T. J Articles by Riddell, S. R Search for Related Content PubMed PubMed Citation Articles by Manley, T. J Articles by Riddell, S. R Social Bookmarking                   What's this?  Previous Article  |  Next Article  Submitted June 16, 2003 Accepted March 10, 2004 Immune Evasion Proteins of Human Cytomegalovirus Do Not Prevent A Diverse CD8+ Cytotoxic T Cell Response In Natural Infection Thomas J Manley*, Lisa Luy, Thomas Jones, Michael Boeckh, Helen Mutimer, and Stanley R Riddell Program In Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle, WA, USA Program In Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Infectious Disease Section, Wyeth Research, Pearl River, NY, USA Program in Infectious Disease, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle, WA, USA * Corresponding author; email: tmanley{at}fhcrc.org. Although cytomegalovirus (CMV) expresses proteins that interfere with antigen presentation by class I MHC molecules, CD8+ cytotoxic T cells (CTL) are indispensable for controlling infection and maintaining latency. Here, a cytokine flow cytometry assay that employs fibroblasts infected with a mutant strain of CMV (RV798), which is deleted of the four viral genes that are responsible for interfering with class I MHC presentation, was used to examine the frequency and specificity of the CD8+ CTL to CMV in immunocompetent CMV seropositive individuals. A large fraction of the CD8+ CTL response was found to be specific for viral antigens expressed during the immediate early and early phases of virus replication and presented by fibroblasts infected with RV798 but not wild type CMV. These results demonstrate that the inhibition of class I antigen presentation observed in CMV-infected cells in vitro is not sufficient to prevent the induction of a broad repertoire of CD8+ CTL after natural infection in vivo. Thus, reconstitution of T-cell immunity in immunodeficient patients by cell therapy or by vaccination may need to target multiple viral antigens to completely restore immunologic control of CMV. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: T. Nishida, M. Hudecek, A. Kostic, M. Bleakley, E. H. Warren, D. Maloney, R. Storb, and S. R. Riddell Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia Clin. Cancer Res., July 15, 2009; 15(14): 4759 - 4768. [Abstract] [Full Text] [PDF] T. Crough and R. Khanna Immunobiology of Human Cytomegalovirus: from Bench to Bedside Clin. Microbiol. Rev., January 1, 2009; 22(1): 76 - 98. [Abstract] [Full Text] [PDF] M. R. Pipeling, E. E. West, C. M. Osborne, A. B. Whitlock, L. K. Dropulic, M. H. Willett, M. Forman, A. Valsamakis, J. B. Orens, D. R. Moller, et al. Differential CMV-Specific CD8+ Effector T Cell Responses in the Lung Allograft Predominate over the Blood during Human Primary Infection J. Immunol., July 1, 2008; 181(1): 546 - 556. [Abstract] [Full Text] [PDF] V. Mersseman, K. Besold, M. J. Reddehase, U. Wolfrum, D. Strand, B. Plachter, and S. Reyda Exogenous introduction of an immunodominant peptide from the non-structural IE1 protein of human cytomegalovirus into the MHC class I presentation pathway by recombinant dense bodies J. Gen. Virol., February 1, 2008; 89(2): 369 - 379. [Abstract] [Full Text] [PDF] E. K. Day, A. J. Carmichael, I. J. M. ten Berge, E. C. P. Waller, J. G. P. Sissons, and M. R. Wills Rapid CD8+ T Cell Repertoire Focusing and Selection of High-Affinity Clones into Memory Following Primary Infection with a Persistent Human Virus: Human Cytomegalovirus J. Immunol., September 1, 2007; 179(5): 3203 - 3213. [Abstract] [Full Text] [PDF] K. Besold, N. Frankenberg, S. Pepperl-Klindworth, J. Kuball, M. Theobald, G. Hahn, and B. Plachter Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion J. Gen. Virol., May 1, 2007; 88(5): 1429 - 1439. [Abstract] [Full Text] [PDF] Y. Yue, A. Kaur, S. S. Zhou, and P. A. Barry Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65). J. Gen. Virol., April 1, 2006; 87(Pt 4): 777 - 787. [Abstract] [Full Text] [PDF] M. W. Munks, M. C. Gold, A. L. Zajac, C. M. Doom, C. S. Morello, D. H. Spector, and A. B. Hill Genome-Wide Analysis Reveals a Highly Diverse CD8 T Cell Response to Murine Cytomegalovirus J. Immunol., March 15, 2006; 176(6): 3760 - 3766. [Abstract] [Full Text] [PDF] J. Yuan, J.-B. Latouche, J. Hodges, A. N. Houghton, G. Heller, M. Sadelain, I. Riviere, and J. W. Young Langerhans-Type Dendritic Cells Genetically Modified to Express Full-Length Antigen Optimally Stimulate CTLs in a CD4-Dependent Manner J. Immunol., February 15, 2006; 176(4): 2357 - 2365. [Abstract] [Full Text] [PDF] O. A. Shlobin, E. E. West, N. Lechtzin, S. M. Miller, M. Borja, J. B. Orens, L. K. Dropulic, and J. F. McDyer Persistent Cytomegalovirus-Specific Memory Responses in the Lung Allograft and Blood following Primary Infection in Lung Transplant Recipients J. Immunol., February 15, 2006; 176(4): 2625 - 2634. [Abstract] [Full Text] [PDF] N. R. Hegde, C. Dunn, D. M. Lewinsohn, M. A. Jarvis, J. A. Nelson, and D. C. Johnson Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL J. Exp. Med., October 17, 2005; 202(8): 1109 - 1119. [Abstract] [Full Text] [PDF] A. W. Sylwester, B. L. Mitchell, J. B. Edgar, C. Taormina, C. Pelte, F. Ruchti, P. R. Sleath, K. H. Grabstein, N. A. Hosken, F. Kern, et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects J. Exp. Med., September 6, 2005; 202(5): 673 - 685. [Abstract] [Full Text] [PDF] N. Khan, R. Bruton, G. S. Taylor, M. Cobbold, T. R. Jones, A. B. Rickinson, and P. A. H. Moss Identification of Cytomegalovirus-Specific Cytotoxic T Lymphocytes In Vitro Is Greatly Enhanced by the Use of Recombinant Virus Lacking the US2 to US11 Region or Modified Vaccinia Virus Ankara Expressing Individual Viral Genes J. Virol., March 1, 2005; 79(5): 2869 - 2879. [Abstract] [Full Text] [PDF] V. A. Pudney, A. M. Leese, A. B. Rickinson, and A. D. Hislop CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells J. Exp. Med., February 7, 2005; 201(3): 349 - 360. [Abstract] [Full Text] [PDF]

	Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020